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Modulation of CD93 molecule in a human monocyte-like cell line (U937) treated with nickel
　 In this study, we demonstrated the modulation of CD93 molecules (both membrane-bound and 
soluble-form) in a human monocyte-like cell line, U937 treated with nickel (Ni2+) to model contact 
hypersensitivity (CHS), such as metal allergy. Ni2+ induced the apoptosis of the U937 cells accompanied 
by the enhanced secretion of an inflammatory cytokine, interleukin-8 (IL-8). The percentages and 
mean fluorescence intensities (MFIs) of membrane-bound CD93 (mCD93) expressed on U937 cells 
were significantly decreased after treatment with Ni2+ when examined using flow cytometry with a 
CD93 monoclonal antibody (mAb) (mNI-11), which was established in our laboratories. In contrast, 
the secretion of soluble-form CD93 (sCD93) from U937 cells increased markedly after treatment with 
Ni2+. Taken together, these findings suggest that the modulation of CD93 molecules (both mCD93 and 
sCD93) might serve as a new biomarker for analyzing the inflammatory reaction in CHS induced by 
Ni2+.
Key words : CD93 molecule, contact hypersensitivity, nickel, U937 cells.
Introduction
　Nickel is a ubiquitous metal used in a wide 
variety of products for health care, household use, 
and architecture. On the other hand, nickel can 
cause metal allergy because of the transfer of nickel 
ions under aqueous conditions 1). Allergies to nickel 
ion (Ni2+) are the most frequent cause of contact 
hypersensitivity (CHS) in industrialized countries 2). 
Sensitization to nickel can occur at any age, even 
in newborns, indicating that the immune system 
in children can present an appropriate response 
to contact allergens from an early age, though 
sensitization might occur less often than in adults 
3-5).
　Human CD93 has a molecular weight (m.w.) of 
about 90-100 kDa and is a heavily O-glycosylated 
type I transmembrane protein consisting of unique 
C-type lectin domains 6). CD93 is selectively 
expressed on myeloid cell lineages (monocytes 
and granulocytes) and endothelial cells and is 
involved in innate and adaptive immune responses 
7). Biologically, CD93 reportedly plays an important 
role in the exclusion/clearance of apoptotic/
damaged cells in various immune responses 8).
　The modulation of membrane-bound CD93 
(mCD93) expression has been investigated in 
various types of cells. We previously reported that a 
protein kinase C activator (PKC), phorbol myristate 
acetate (PMA), effectively up-regulated mCD93 
expression in several cultured cell lines 9).
　Meanwhile, CD93 is reportedly shed/secreted 
from the surface of activated human monocytes 
and granulocytes (neutrophils) in vitro, resulting 
in the shedding/secretion of a soluble-form of 
CD93 (sCD93) 10). In particular, sCD93 shedding 
was detected in vitro in response to inflammatory 
mediators, such as tumor-necrosis factor (TNF)-
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α and interleukin-8 (IL-8) (which are related to 
allergy development), endotoxin lipopolysaccharide 
(LPS), and PMA 10 - 12). Therefore, we can easily 
hypothesize that the modulation of mCD93 and 
sCD93 is closely associated with various diseases 
involving inflammation, including allergy.
　In the present study, to analyze the roles of 
the CD93 molecule in allergy with inflammation 
induced by Ni2+, we established a new CD93 
monoclonal antibody (mAb) (mNI-11) 6, 13) and 
demonstrated the modulation of mCD93 and sCD93 
in a human monocyte-like cell line (U937) treated 
with Ni2+, using the above-mentioned mAb as a 
probe for the analysis. 
Materials and Methods
Cell line
　The human monocyte-like cell line (U937) used 
in the present study was supplied by the Health 
Science Research Resource Bank (HSRRB) (Tokyo, 
Japan). U937 cells were cultured in RPMI 1640 
medium (GIBCO) supplemented with 10 mM HEPES 
buffer, 2 mM glutamine and 10% fetal calf serum 
(FCS) (referred to as complete medium). 
Antibodies and reagents
　Nickel (NiSO4 6H2O) was purchased from 
Nakarai Tesque Co. (Tokyo, Japan) and dissolved 
in distilled water at a concentration of 10 mM 
(Ni2+). Horseradish peroxidase (HRPOD)-conjugated 
streptavidin was purchased from Cosmo Bio Co. 
(Tokyo, Japan). Phycoerythrin (PE)-conjugated 
and non-conjugated CD93 monoclonal antibodies 
(mAbs) (mNI-11; mouse IgG1) 6, 13) were established 
in our laboratories. PE-conjugated isotype-matched 
normal mouse IgG1 was purchased from MBL Co. 
(Nagoya, Japan). A biotin-conjugated CD93 mAb 
(X-2; mouse IgG1) was purchased from Cosmo 
Bio Co. (Tokyo, Japan). Recombinant CD93 
protein (TP306980) was purchased from OriGene 
Technologies, Inc. (USA). 
Preparation of U937 cells treated with Ni2+
　U937 cells (1x105) in complete medium were 
seeded in 96-well plates (Sumitomo Co., Tokyo) and 
treated with or without various concentrations of 
Ni2+ for 16 hrs in a CO2 incubator. The treated cells 
were harvested, and the modulation of membrane-
bound CD93 (mCD93) expression was analyzed 
using flow cytometry with a PE-conjugated CD93 
mAb (mNI-11). Culture supernatants were used to 
detect soluble-form CD93 (sCD93) or interleukin-8 
(IL-8) using an enzyme-linked immunoassay (EIA) 
system, respectively.
Detection of apoptotic cells 
　The enrichment of mono- and oligonucleosomes 
in the cytoplasm of apoptotic cells suggests that 
DNA degradation occurs before plasma membrane 
breakdown. Thus, we performed apoptotic 
monitoring of U937 cells treated with or without 
various concentrations of Ni2+ by determining 
the presence of mono- and oligonucleosomes 
in the cytoplasmic fraction of cell lysates using 
an apoptosis detection EIA kit (Roche Applied 
Science). These experiments were repeated five 
times.
Flow cytometry
　U937 cells (1x105) treated with or without various 
concentrations of Ni2+ for 16 hrs were washed in 
cold phosphate-buffered saline (PBS) containing 
0.1% NaN3 (referred to as washing buffer), and 
incubated in PBS containing 25% normal goat 
serum, 1 mg/mL normal human IgG and 0.1% 
NaN3 to block the Fc receptor (FcR) for IgG for 10 
min on ice. After washing three times, the cells 
were incubated with an optimal concentration of 
PE-conjugated CD93 mAb (mNI-11) for 30 min at 
room temperature. Isotype-matched PE-conjugated 
normal mouse IgG1 was used as a negative control. 
After washing twice in the washing buffer, the cells 
were re-suspension in PBS containing 2% FCS and 
0.1% NaN3. The percentages and mean fluorescence 
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intensities (MFIs) of positively stained cells for the 
CD93 mAb (mNI-11) were determined by the use 
of the FACScan system (Becton Dickinson Co.). The 
experiment was repeated three times.
Assay for soluble-form CD93 (sCD93) in culture 
supernatants 
　Enzyme immunoassay (EIA) plates (Sumitomo 
Co., Tokyo) were coated with 500 ng/mL of CD93 
mAb (mNI-11) for 18 hrs in carbonate biocarbonate 
buffer (0.01M NaCO3, 0.035M NaHCO3, pH9.6) 
at 4℃. The wells were then washed five times 
with PBS containing 0.05% Tween 20 (PBS-T) and 
blocked with PBS-T containing 2% BSA for 60 min 
at room temperature. Culture supernatant (50μ
L) from U937 cells treated with or without various 
concentrations of Ni2+ for 16 hrs was then added 
to each well. A purified recombinant protein of 
CD93 (TP306980) was added to each well as a 
positive or standard control. Thereafter, 50μL of 
biotin-conjugated CD93 mAb (X-2) (x5000 dilution 
with PBS-T containing 0.1% BSA) was added to 
each well, followed by incubation for 60 min at 
room temperature with shaking. The wells were 
washed eight times with PBS-T, and 100μL of 
HRPOD-conjugated streptavidin (x5000 dilution 
with PBS-T containing 0.1% BSA) was added 
to each well and incubated for 30 min at room 
temperature with shaking. The wells were washed 
nine times with PBS-T, and 100μL of the substrate-
chromogen (TMB) (Cosmo Bio Co.) was added to 
each well, followed by 5-10 min of incubation at 
room temperature. The reaction was stopped by 
the addition of 0.5-N HCl, and the optical density 
(O.D.) was read at 450 nm using a multichannel 
EIA microplate reader (TOHSO Co., Tokyo). The 
experiment was repeated five times.
Assay for interleukin-8 (IL-8) in culture 
supernatants 
　The detection of IL-8 in culture supernatants 
from U937 cells treated with or without various 
concentrations of Ni2+ for 16 hrs was performed 
using an IL-8 detection EIA kit (MBL Co.). The 
experiments were repeated three times. 
Results 
Induction of apoptosis in U937 cells treated with 
Ni2+
　We performed apoptotic monitoring of the U937 
cells treated with or without various concentrations 
of Ni2+ using an apoptosis detection EIA kit. Figure 
1 shows that apoptosis was strongly induced in 
U937 cells treated with Ni2+ in a dose-dependent 
manner. 
Enhancement of IL-8 secretion from U937 cells 
treated with Ni2+  
　IL-8 secretion from U937 cells treated with 
or without various concentrations of Ni2+ was 
evaluated using an EIA kit. As shown in Fig. 
2, treatment with Ni2+ significantly (P < 0.05) 
enhanced IL-8 secretion from U937 cells into the 
culture supernatants. 
Decrease in membrane-bound CD93 (mCD93) 
expression on U937 cells treated with Ni2+
　mCD93 expression on U937 cells treated with 
or without various concentrations of Ni2+ was 
analyzed using a CD93 mAb (mNI-11) and a flow 
cytometry analysis. Figure 3 shows that both the 
percentages and the mean fluorescence intensities 
(MFIs) of mCD93 expression on U937 cells 
decreased significantly after treatment with Ni2+ (P 
< 0.05). Figure 4 shows the typical flow cytometric 
profiles of mCD93 expression patterns in U937 cells 
treated with or without Ni2+. 
Increase in soluble-form CD93 (sCD93) 
secretion from U937 cells treated with Ni2+
　sCD93 secretion from U937 cells treated with 
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or without various concentrations of Ni2+ was 
demonstrated using an EIA system originally 
constructed in our laboratories. As shown in Fig. 
5, Ni2+ treatment significantly (P < 0.05) increased 
sCD93 secretion from U937 cells into the culture 
supernatants in a dose-dependent manner. 
Discussion
　In this study, we found that mCD93 expression on 
U937 cells treated with Ni2+ decreased significantly, 
while sCD93 secretion from this same cell line 
under the same conditions increased significantly 
accompanied by the enhancement of IL-8 secretion 
during the apoptotic process.                                               
　We can suggest some possible reasons for the 
decrease of mCD93 on U937 cells treated with Ni2+. 
One possible reason for the decrease of mCD93 
expression is the shedding/release of this molecule 
from the cell membrane after treatment with Ni2+. 
In fact, the amount of secreted sCD93 in the culture 
supernatants from U937 cells increased significantly 
after treatment with Ni2+. Another reason for the 
decrease in mCD93 expression on U937 cells 
treated with Ni2+ might be the suppression of the 
phosphorylation (unphosphorylation) of some 
proteins via the action of protein kinases (PKCs). 
　In the modulation of mCD93, we previously 
reported that a PKC activator, phorbol myristate 
acetate (PMA), effectively up-regulated mCD93 
expression on several cultured cell lines, including 
U937 cells, through the phosphorylation of some 
protein(s) by PKC delta isoenzyme 9). Furthermore, 
since the glycosylation of the CD93 molecule is 
an important factor for the stability of cell surface 
expression 14), the decrease in mCD93 expression 
on U937 cells treated with Ni2+ may depend 
on unglycosylation through the suppression of 
phosphorylation.
　Moreover, we previously reported that the 
expression of mCD93 is specifically decreased by 
various apoptosis-induced chemical substances 15) 
and anti-CD95 (anti-Fas) mAb (CH-11) 16). Thus, 
the decrease of mCD93 expression on U937 cells 
treated with Ni2+ may be associated with some 
intracellular apoptotic signals. In fact, U937 cells 
treated with Ni2+ underwent apoptosis, as indicated 
by the DNA degradation that was identified by the 
production of mono- and oligonucleosomes in the 
cytoplasmic fraction. 
　On the other hand, mCD93 is reportedly shed 
from activated human myeloid cells (monocytes 
and neutrophils) as the shedding/secretion of 
sCD93 10). In particular, sCD93 shedding/secretion 
was detected in vitro in response to treatment with 
LPS, TNF-α, IL-8 and PMA 10-12). Therefore, we 
can easily suggest that the modulation of sCD93 
secretion is tightly associated with inflammatory 
responses. In fact, several studies have reported 
that sCD93 shedding/secretion is closely related to 
some diseases with inflammation in humans and 
mice 11, 17).
　Recently, toll-like receptor (TLR)-4, T cell 
receptors (TCRs), and some co-stimulatory CD 
molecules were reported to play crucial roles in the 
inducement/development of contact hypersensitivity 
(CHS) in response to Ni2+ 18, 19). Thus, cross-talk 
signal(s) through TLR, TCRs, and co-stimulatory CD 
molecules, such as the CD93 molecule, in response 
to Ni2+ might be involved in the development of 
allergy with inflammation. Although the detailed 
reasons for the decrease in mCD93 expression 
and the increase in sCD93 secretion from U937 
cells treated with Ni2+ are not fully understood 
at the present time, we are vigorously analyzing 
the detailed mechanism(s) concerning these 
immunological phenomena.
　In conclusion, we observed a decrease in 
mCD93 expression and an increase in sCD93 
secretion in U937 cells treated with Ni2+. These 
findings strongly suggest that the modulation of 
CD93 molecules (both mCD93 and sCD93) may 
serve as a new biomarker for analyzing CHS with 
inflammation induced by Ni2+. Further analyses are 
needed to elucidate the detailed intracellular signal 
transduction mechanism(s) of these findings at the 
molecular level.
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Figure 1. Induction of apoptosis in U937 cells treated with Ni2+. Apoptotic monitoring of U937 cells treated with or without 
Ni2+ was performed using an apoptosis detection EIA kit (See Materials and Methods for details). Data were represented as 
the mean ± SD. The analysis was repeated in triplicate per sample. The experiment was repeated three times. *P < 0.05 (vs. 0 
μM).
Figure 2. Enhancement of IL-8 secretion from U937 cells treated with Ni2+. Detection of IL-8 in the supernatants from U937 
cells treated with or without Ni2+ was performed using an IL-8 detection EIA kit (See Materials and Methods for details). Data 
were represented as the mean ± SD. The analysis was repeated in triplicate per sample. The experiment was repeated three 
times. *P < 0.05 (vs. 0μM).
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Figure 3. Decrease in mCD93 expression on U937 cells treated with Ni2+. The percentages (panel A) and mean fluorescence 
intensities (MFIs) (panel B) of mCD93 expression on U937 cells treated with or without Ni2+ were analyzed using a single-
color flow cytometric system (See Materials and Methods for details). Data were represented as the mean ± SD. The analysis 
was repeated in triplicate per sample. The experiment was repeated three times. #P < 0.05 (vs. 0μM).*P < 0.05 (vs. 0μM).
Figure 4. Typical flow cytometric profiles of mCD93 on U937 cells treated with Ni2+. The percentages and mean fluorescence 
intensities (MFIs) of mCD93 expression on U937 cells treated with or without Ni2+ were analyzed using a single-color 
flow cytometric system (See Materials and Methods for details). The arrow within the upper panel indicates the analysis 
population. Percentages and MFIs are expressed in each panel. The values in parentheses are the MFIs.
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Figure 5. Increase in sCD93 secretion from U937 cells treated with Ni2+. The detection of sCD93 in supernatants from U937 
cells treated with or without Ni2+ was performed using an EIA system (See Materials and Methods for details). Data were 
represented as the mean ± SD. The analysis was repeated in triplicate per sample. The experiment was repeated three times. 
*P < 0.05 (vs. 0μM).
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　ニッケルで処理されたヒト単球系細胞株（U937）における CD93 分子の動態を解析した。ニッケル処理は
U937 細胞に対してインターロイキン -8(IL-8) の産生を増強しながらアポトーシスを誘導した。また、ニッケ
ル処理により U937 細胞表面上の CD93 分子（mCD93）の発現は有意に減少し、可溶性 CD93 分子（sCD93）
の産生は有意に増強した。以上の結果は、CD93 分子の動態が金属（ニッケル）アレルギーの発症メカニズム
を解析するための新たなバイオマーカーに成り得ることを示唆している。
キーワード：CD93 分子、接触過敏、ニッケル、U937 細胞
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